Pfizer to buy weight-loss drug developer Metsera
Pfizer said today it would acquire weight-loss drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, to secure its position in the lucrative obesity treatment market.
Business
• 22 Sep
